OCRF & Ovarian Cancer National Alliance are now one strong, united, inspiring voice!
Ovarian Cancer Research Fund (OCRF) and the Ovarian Cancer National Alliance (OCNA) have led the way in advocacy, research and support for patients and their families for over 22 years. As of January 2016, we are pleased to announce we are joining together to form Ovarian Cancer Research Fund Alliance (OCRFA), the largest global organization dedicated to advancing ovarian cancer research while supporting women and their families. Read the exciting news!

XClose

1999 Individual Investigator Grant Recipient – Dineo Khabele

Dineo Khabele, M.D.
Albert Einstein College of Medicine/Montefiore Medical Center
Patterns of Gene Expression in Ovarian Cancer

Project Summary

Dr. Khabele will use microarray-based analysis for the examination of the expression of multiple genes in cell culture specimens from patients with ovarian cancer. Using the method, Dr. Khabele hopes to identify new gene mutations in ovarian cancer and to detect differences in the gene expression among different stages of ovarian cancers, ranging from normal tissue to advanced stages of disease. Microarray analysis may make it also possible to assess prognosis based on the initial study of gene expression of a particular specimen. The findings someday may allow the discovery of new biomarkers for early diagnosis and follow-up, and the assessment of specific genetic sites for intervention and therapy.

Bio

Dr. Khabele is the Director, Gynecologic Oncology & Women’s Cancer Research Laboratory at Meharry Medical College, and an Assistant Professor of Obstetrics and Gynecology and of Cancer Biology at Vanderbilt-Ingram Cancer Center.